GB430280A - Method of extracting cardio-active principles of squill - Google Patents

Method of extracting cardio-active principles of squill

Info

Publication number
GB430280A
GB430280A GB2127134A GB2127134A GB430280A GB 430280 A GB430280 A GB 430280A GB 2127134 A GB2127134 A GB 2127134A GB 2127134 A GB2127134 A GB 2127134A GB 430280 A GB430280 A GB 430280A
Authority
GB
United Kingdom
Prior art keywords
solution
principles
principle
product
aqueous solution
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
GB2127134A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
GRISARD LAB Inc
Original Assignee
GRISARD LAB Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by GRISARD LAB Inc filed Critical GRISARD LAB Inc
Priority to GB2127134A priority Critical patent/GB430280A/en
Publication of GB430280A publication Critical patent/GB430280A/en
Expired legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/88Liliopsida (monocotyledons)
    • A61K36/896Liliaceae (Lily family), e.g. daylily, plantain lily, Hyacinth or narcissus

Landscapes

  • Health & Medical Sciences (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Biotechnology (AREA)
  • Botany (AREA)
  • Medical Informatics (AREA)
  • Medicinal Chemistry (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Manufacture And Refinement Of Metals (AREA)

Abstract

Squill is macerated with a water-miscible organic solvent such as denatured alcohol, the solution is evaporated and the residue dissolved in water. The aqueous solution is agitated with an organic solvent not miscible with water, e.g. petroleum ether, to dissolve out scillin, fats and oils. The active principles are precipitated from the purified aqueous solution with tannic acid, a salt such as sodium chloride being added to complete the precipitation. The precipitated tannates are decomposed with an inorganic oxide or hydroxide such as zinc oxide. The product is separated into three distinct cardio-active substances by the following procedure. The aqueous solution of the product is agitated with a solvent such as absolute ethyl acetate which dissolves principles I and II. Principle III is recovered from the aqueous solution by precipitation with tannic acid, decomposition of the tannate with a metallic oxide, and recrystallization of the product from absolute ethyl alcohol. The solution of principles I and II is evaporated, redissolved in chloroform, and agitated with dilute aqueous alkaline carbonate solution which dissolves principle II. This solution is neutralized and treated with a non-miscible solvent such as ethyl acetate from which principle II is obtained by evaporation. The chloroform solution of principle I is evaporated and the product recrystallized from ethyl acetate. The combustion analysis and physical properties of the three principles are described. They are all readily hydrolyzed, producing aglycones.ALSO:Squill is macerated with a water-miscible organic solvent such as denatured alcohol, the solution is evaporated and the residue dissolved in water. The aqueous solution is agitated with an organic solvent not miscible with water, e.g. petroleum ether, to dissolve out scillin, fats, and oils. The active principles are precipitated from the purified aqueous solution with tannic acid, a salt such as sodium chloride being added to complete the precipitation. The precipitated tannates are decomposed with an inorganic oxide or hydroxide such as zinc oxide. The product is separated into three distinct cardio-active substances by the following procedure. The aqueous solution of the product is agitated with a solvent such as absolute ethyl acetate which dissolves principles I and II. Principle III is recovered from the aqueous solution by precipitation with tannic acid, decomposition of the tannate with a metallic oxide, and recrystallization of the product from absolute ethyl alcohol. The solution of principles I and II is evaporated, redissolved in chloroform, and agitated with dilute aqueous alkaline carbonate solution which dissolves principle II. This solution is neutralized and treated with a non-miscible solvent such as ethyl p acetate from which principle II is obtained by evaporation. The chloroform solution of principle I is evaporated and the product recrystallized from ethyl acetate. The combustion analysis and physical properties of the three principles are described. They are all readily hydrolyzed, producing aglycones.
GB2127134A 1934-07-20 1934-07-20 Method of extracting cardio-active principles of squill Expired GB430280A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
GB2127134A GB430280A (en) 1934-07-20 1934-07-20 Method of extracting cardio-active principles of squill

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB2127134A GB430280A (en) 1934-07-20 1934-07-20 Method of extracting cardio-active principles of squill

Publications (1)

Publication Number Publication Date
GB430280A true GB430280A (en) 1935-06-17

Family

ID=10160089

Family Applications (1)

Application Number Title Priority Date Filing Date
GB2127134A Expired GB430280A (en) 1934-07-20 1934-07-20 Method of extracting cardio-active principles of squill

Country Status (1)

Country Link
GB (1) GB430280A (en)

Similar Documents

Publication Publication Date Title
GB430280A (en) Method of extracting cardio-active principles of squill
GB1204514A (en) Process for the manufacture of alkali paraffin sulphonate solutions containing small amounts of alkali sulphate
GB227122A (en) Improvements in process for obtaining certain remedial principles of oils
US2562200A (en) Process for making d-glucuronic acid and its salts
GB486898A (en) Manufacture of substances resembling vitamines from plants
GB482125A (en) Process for the preparation of new hormones from the male sex apparatus and the new hormones obtained by such process
GB747744A (en) Process for the preparation of 3-acetyl-4-hydroxycoumarin
DE448536C (en) Process for obtaining the heart-active pure glycoside from Bulbus Scillae
GB535572A (en) New crystallised glucoside and a process for its isolation from red squill
GB393635A (en) A method of obtaining a substance which reduces hyperglycemia
GB687843A (en) Methods of treating and processing animal and vegetable oils
Funk et al. The male hormone. IV
GB220697A (en) A process for the extraction of the fat-soluble vitamin
GB208145A (en) Improvements in process for obtaining certain remedial principles of oils
GB486064A (en) A process for obtaining a substance lowering the blood pressure
GB425387A (en) Improvements relating to the manufacture of organic bismuth salts
GB1049770A (en) Production of omega aminoketocarboxylic acids
GB446703A (en) Process for the manufacture of phenyl mercury nitrates
SU523136A1 (en) The method of obtaining surfactants
GB396135A (en) Manufacture of an adenosine phosphoric acid
GB451203A (en) Process for the manufacture of desoxymorphine c and dihydrodesoxymorphine d
Stammers On the presence of α-hydroxy acids in blood
GB357926A (en) Manufacture of a new crystallized product from digitalis
GB485731A (en) Improvements in and relating to a process for the manufacture of thrombin
GB900126A (en) Process for refining of vegetable protein